阿片类与兴奋剂使用障碍诊断与有监禁史人群致死及非致死性过量的关联
该研究基于不列颠哥伦比亚省省级过量队列(20%随机居民样本),纳入2010年1月1日至2014年12月31日期间有监禁史的6816人,随访5年(2015年1月1日至2019年12月31日)。暴露为物质使用障碍诊断类型(仅阿片类、仅兴奋剂、两者兼有、均无)。随访期间1655人发生4026次过量,其中非致死性3781次(93.9%),致死性245次(6.1%)。校正分析显示,同时有阿片类和兴奋剂使用障碍诊断者致死性(HR 2.39;95%CI 1.48-3.86)和非致死性(HR 2.45;95%CI 1.94-3.11)过量风险最高。作者认为,亟需关注与刑事司法系统有过接触且同时使用阿片类和兴奋剂者的服务需求。
要点
- 在有监禁史的6816人中,仅阿片类使用障碍293人(4.3%),仅兴奋剂使用障碍395人(6.8%),两者兼有281人(4.1%)。
- 随访期间1655人发生4026次过量,其中非致死性3781次(93.9%),致死性245次(6.1%)。
- 同时有阿片类和兴奋剂使用障碍诊断者致死性过量风险最高(HR 2.39;95%CI 1.48-3.86)。
- 同时有阿片类和兴奋剂使用障碍诊断者非致死性过量风险最高(HR 2.45;95%CI 1.94-3.11)。
- 作者认为,亟需关注与刑事司法系统有过接触且同时使用阿片类和兴奋剂者的服务需求。
适用人群与场景
- 不列颠哥伦比亚省省级过量队列中20%随机居民样本里,2010年1月1日至2014年12月31日期间有监禁史的全部人群。
- 共6816人,其中男性5980人(87.7%),年龄<30岁者2820人(41.4%)。
研究设计与关键结果
- 研究类型为队列研究,数据来自不列颠哥伦比亚省省级过量队列(20%随机居民样本),纳入有监禁史的6816人,随访5年(2015年1月1日至2019年12月31日)。
- 暴露分组:仅阿片类使用障碍293人(4.3%),仅兴奋剂使用障碍395人(6.8%),两者兼有281人(4.1%)。
- 随访期间1655人发生4026次过量,其中非致死性3781次(93.9%),致死性245次(6.1%)。
- 校正分析中,同时有阿片类和兴奋剂使用障碍诊断者致死性过量风险最高(HR 2.39;95%CI 1.48-3.86)。
- 校正分析中,同时有阿片类和兴奋剂使用障碍诊断者非致死性过量风险最高(HR 2.45;95%CI 1.94-3.11)。
证据类型、等级与局限
- 证据类型:队列研究;统计分析方法为Andersen-Gill模型(复发性非致死性过量事件)和Fine and Gray竞争风险模型(致死性过量事件)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,亟需关注与刑事司法系统有过接触且同时使用阿片类和兴奋剂者的服务需求。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Studies have suggested a rise in opioid- and stimulant-involved overdoses in recent years in North America. This risk may be acute for individuals who have had contact with the criminal justice system, who are particularly vulnerable to overdose risk.
OBJECTIVE: To examine the association of opioid and/or stimulant use disorder diagnoses with overdose (fatal and nonfatal) among people with histories of incarceration.
DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, population-based health and corrections data were retrieved from the British Columbia Provincial Overdose Cohort, which contains a 20% random sample of residents of British Columbia. The analysis included all people in the 20% random sample who had a history of incarceration between January 1, 2010, and December 31, 2014. Outcomes were derived from 5-years of follow-up data (January 1, 2015, to December 31, 2019). Statistical analysis took place from January 2022 to June 2022.
EXPOSURES: Substance use disorder diagnosis type (ie, opioid use disorder, stimulant use disorder, both, or neither), sociodemographic, health, and incarceration characteristics.
MAIN OUTCOMES AND MEASURES: Hazard ratios (HRs) are reported from an Andersen-Gill model for recurrent nonfatal overdose events and from a Fine and Gray competing risk model for fatal overdose events.
RESULTS: The study identified 6816 people (5980 male [87.7%]; 2820 aged <30 years [41.4%]) with histories of incarceration. Of these, 293 (4.3%) had opioid use disorder only, 395 (6.8%) had stimulant use disorder only, and 281 (4.1%) had both diagnoses. During follow-up, 1655 people experienced 4026 overdoses including 3781 (93.9%) nonfatal overdoses, and 245 (6.1%) fatal overdoses. In adjusted analyses, the hazard of both fatal (HR, 2.39; 95% CI, 1.48-3.86) and nonfatal (HR, 2.45; 95% CI, 1.94-3.11) overdose was highest in the group with both opioid and stimulant use disorder diagnoses.
CONCLUSIONS AND RELEVANCE: This cohort study of people with a history of incarceration found an elevated hazard of fatal and nonfatal overdose among people with both opioid and stimulant use disorder diagnoses. This study suggests an urgent need to address the service needs of individuals who have had contact with the criminal justice system and who co-use opioids and stimulants.
参考来源
- Palis H, Gan W, Xavier C, et al. Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration. JAMA Netw Open. 2022. PMID: 36416821. doi:10.1001/jamanetworkopen.2022.43653
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。